Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors - Drug Trials For Money - Paid Clinical Trials

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
Conditions:   Metastatic Malignant Solid Neoplasm;   Recurrent Malignant Solid Neoplasm;   Recurrent Platinum-Resistant Ovarian Carcinoma;   Refractory Ovarian Carcinoma
Interventions:   Drug: BET Bromodomain Inhibitor ZEN-3694;   Biological: Ipilimumab;   Biological: Nivolumab
Sponsor:   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 1, 2022 / by / in
Comments